Bortezomib: Potential Key Role in the Treatment of Multiple Myeloma-Related Acquired Hemophilia A

Bortezomib: Potential Key Role in the Treatment of Multiple Myeloma-Related Acquired Hemophilia A

Saved in:
Bibliographic Details
Published in:Seminars in thrombosis and hemostasis Vol. 43; no. 1; p. 109
Main Authors: Brás, Gil de Paiva, Pinto, Ricardo Jorge Sancio Moreira, Carvalho, Maria Manuela Marques Cardoso, Fernandes, Susana Patrícia Beleza Nobre, Andrade, Joaquim José Aguiar, Guimarães, José Eduardo Torres Eckenroth
Format: Journal Article
Language:English
Published: United States 01-02-2017
Subjects:
Aged, 80 and over
Antineoplastic Agents - administration & dosage
Antineoplastic Agents - therapeutic use
Bortezomib - administration & dosage
Bortezomib - therapeutic use
Hemophilia A - drug therapy
Hemophilia A - etiology
Humans
Male
Multiple Myeloma - complications
Multiple Myeloma - drug therapy
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-9064
DOI:10.1055/s-0036-1597648